Changchun Bcht Biotechnology Co.

This early-stage study tests a new vaccine that protects against whooping cough, diphtheria, and tetanus in people aged 10 and older. Researchers will check if different doses are safe and trigger a strong immune response. About 96 volunteers will receive either the vaccine or a …

This early-stage trial tests a new flu vaccine that includes an adjuvant (BK-01) to boost the immune response. About 160 adults aged 18 and older will receive either the new vaccine, a standard flu vaccine, or a placebo. The main goal is to check safety and how well the vaccine t…